Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/29639

Type
Article
Copyright
Open access
Collections
Share

Statistics
Metadata
Show full item record

WHY START? REFLECTIONS THAT LED TO THE CONDUCT OF THIS LARGE LONG-TERM STRATEGIC HIV TRIAL
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group | Date Issued: 2015
Author
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group
Keywords
CD4-guided ART
HIV
START trial
Antiretroviral therapy
When to start
 
Citation
The INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Why START? Reflections That Led to the Conduct of This Large Long-Term Strategic HIV Trial. HIV medicine, v. 16, suppl 1, p. 1–9, 2015
DOI
10.1111/hiv.12227
ISSN
1464-2662
Notes
Presentes no INSIGHT Strategic Timing of AntiRetroviral Treatment Study Group: Beatriz Grinsztejn; Sandra Wagner Cardoso (Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil).